SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,346 | -25.4% | 25,748 | 0.0% | 0.00% | – |
| Q2 2023 | $119,728 | +25.4% | 25,748 | +24.6% | 0.00% | – |
| Q1 2023 | $95,482 | -42.8% | 20,667 | 0.0% | 0.00% | – |
| Q4 2022 | $166,989 | +60.0% | 20,667 | +9.9% | 0.00% | – |
| Q3 2022 | $104,357 | +0.5% | 18,803 | -5.7% | 0.00% | – |
| Q2 2022 | $103,861 | -32.7% | 19,935 | +6.2% | 0.00% | – |
| Q1 2022 | $154,306 | -54.6% | 18,772 | -17.9% | 0.00% | – |
| Q4 2021 | $340,000 | -21.8% | 22,872 | -0.6% | 0.00% | – |
| Q3 2021 | $435,000 | -6.0% | 23,004 | -7.6% | 0.00% | – |
| Q2 2021 | $463,000 | +7.9% | 24,887 | +32.1% | 0.00% | – |
| Q1 2021 | $429,000 | +14.7% | 18,833 | +9.3% | 0.00% | – |
| Q4 2020 | $374,000 | +152.7% | 17,228 | +16.6% | 0.00% | – |
| Q3 2020 | $148,000 | +59.1% | 14,774 | +25.0% | 0.00% | – |
| Q2 2020 | $93,000 | – | 11,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |